| Literature DB >> 31327282 |
Gang Fan1, Yanbin Meng2, Shuai Zhu1, Mingji Ye1, Mingfeng Li1,3, Feiping Li4, Yuanchun Ye5, Zhizhong Liu1, Han Weiqin1, Yu Xie1.
Abstract
Entities:
Keywords: Three-dimensional printing; kidney neoplasms; laparoscopic partial nephrectomy; renal cancer; surgical blood loss; surgical time; warm ischemia time
Mesh:
Year: 2019 PMID: 31327282 PMCID: PMC6753553 DOI: 10.1177/0300060519862058
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.Traditional two-dimensional computed tomography image of the kidney, used in lateral partial nephrectomy.
Figure 3.Three-dimensional (3D)-printed physical anatomic models used for surgical planning and navigation. a, b: 3D-printed physical anatomic models used to identify the location of the kidney tumor during surgical planning. c: 3D-printed physical anatomic model used during intraoperative navigation to facilitate rapid and accurate establishment of tumor position and assist with exposure of the tumor area.
Baseline demographic and clinical characteristics.
| Patient demographics | 3D-LPN group (n = 69) | LPN group (n = 58) | |
|---|---|---|---|
| Age (years), mean (±SD, range) | 48.0 (±11.9, 24–75) | 50.0 (±11.4, 26–70) | >0.05 |
| Sex (male/female), n | 38/31 | 26/32 | >0.05 |
| BMI (kg/m2) mean (±SD, range) | 23.7 (±3.0, 17.7–32.0) | 23.2 (±4.4, 17.8–34.9) | >0.05 |
| ASA status (Grade I/II/III), n | 44/20/5 | 34/21/3 | >0.05 |
| Tumor size (cm), mean (±SD, range) | 4.0 (±2.6, 1.5–11.0) | 3.9 (±1.4, 1.2–6.7) | >0.05 |
| Left/Right, n | 35/34 | 25/33 | >0.05 |
| RENAL score (<8/≥8), n | 33/36 | 39/19 | >0.05 |
| Surgical approach (retro/trans-peritoneal), n | 41/28 | 37/21 | >0.05 |
LPN, laparoscopic partial nephrectomy; SD, standard deviation; BMI, body mass index; ASA, American Society of Anesthesiologists.
Operative parameters and clinical outcomes.
| Patient Demographics | 3D-LPN Group (n = 69) | LPN Group (n = 58) | |
|---|---|---|---|
| OT (minutes), mean ± SD) | 169.7 (±56.4) | 159.2 (±39.6) | >0.05 |
| WIT (minutes), mean (±SD) | 24.1 (±5.1) | 26.6 (±4.2) | <0.05 |
| EIBL (mL), mean (±SD) | 118.7 (±83.6) | 131.1 (±80.2) | >0.05 |
| EPBL (mL), mean (±SD) | 162.6 (±155.6) | 187.1 (±143.9) | >0.05 |
| ICL (mg/dL), mean (±SD) | 13.9 (±3.0) | 23.2 (±5.7) | >0.05 |
| Positive margins, n (%) | 0 (0) | 0 (0) | |
| Histology of primary lesion, n | |||
| Clear cell | 48 | 45 | |
| Papillary | 15 | 8 | |
| Chromophobe cell | 4 | 2 | |
| Others | 2 | 3 | |
| Complications, n (%) | 6 (8.7) | 8 (13.8) | >0.05 |
| Surgery waiting times (days), mean (±SD) | 13.6 (±3.4) | 7.0 (±0.6) | <0.05 |
*Statistically significant difference.
LPN, laparoscopic partial nephrectomy; OT, operative time; SD, standard deviation; WIT, warm ischemia time; EIBL, estimated intraoperative blood loss; EPBL, estimated postoperative blood loss; ICL, increased creatinine level.
Operative parameters and clinical outcomes according to RENAL scores.
| Variable | RENAL score | |||||
|---|---|---|---|---|---|---|
<8 | ≥ 8 | |||||
| 3D-LPN group (n = 33) | LPN Group (n = 39) | 3D-LPN group (n = 36) | LPN group (n = 19) | |||
| OT (minutes), mean (±SD) | 147.0 (±39.6) | 154.6 (±33.2) | >0.05 | 190.5 (±61.7) | 168.4 (±49.9) | >0.05 |
| WIT (minutes), mean (±SD) | 23.4 (±5.0) | 25.4 (±4.4) | >0.05 | 24.6 (±4.3) | 29.2 (±2.3) | <0.05 |
| EIBL (mL), mean (±SD) | 102.7 (±87.5) | 107.7 (±72.1) | >0.05 | 131.9 (±78.5) | 179.2 (±76.1) | <0.05 |
| EPBL (mL), mean (±SD) | 142.0 (±88.6) | 153.9 (±150.9) | >0.05 | 191.4 (±193.6) | 214.0 (±122.1) | >0.05 |
| ICL (mg/dL), mean (±SD) | 18.9 (±13.6) | 28.8 (±21.0) | >0.05 | 22.2 (±20.2) | 19.4 (±21.1) | >0.05 |
| Complications, n (%) | 3 (9.1) | 3 (7.7) | >0.05 | 3 (8.3) | 5 (26.3) | >0.05 |
*Statistically significant difference.
LPN, laparoscopic partial nephrectomy; OT, operative time; SD, standard deviation; WIT, warm ischemia time; EIBL, estimated intraoperative blood loss; EPBL, estimated postoperative blood loss; ICL, increased creatinine level.